Clinical trials demonstrate robust HbA1c lowering and modest weight reduction
It is therefore apparent that most studies in this area have been limited by small sample size (and therefore reduced power) and that most have focused on the acute effect of metformin therapy as opposed to its longer term effects
EMR is successful at removing these focal areas, but there still is the risk of scarring and the potential for strictures
Not suitable for those monitoring blood sugar or trying to avoid glucose spikes
Well review your medical history, discuss potential benefits and limitations, and determine if this offlabel treatment is right for you
Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF, STEP 1 Study Group